Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

This Stock Has Quadrupled in 5 Years. Can It Do It Again?

TheMotleyFool

0 0

This Stock Has Quadrupled in 5 Years. Can It Do It Again?: https://g.foolcdn.com/editorial/images/754141/physician-shaking-patients-hand.jpg

It's been a solid year for Krystal Biotech (NASDAQ: KRYS), a midcap company focusing on developing gene therapies, as it has easily outperformed the market this year. However, zooming out tells an even more impressive story: In the past five years, its shares have risen by 384% -- more than quadrupling in this period.

The company owes this performance to solid clinical and regulatory progress. But can it pull off something similar in the next half a decade? Let's find out.

KRYS data by YCharts.